glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginine

09/01/2015 - "Both the low impact aerobic dance and fitball training group and the low impact aerobic dance training group revealed their lower level of bone resorption (β-CrossLaps) while the first group showed statistically significant change (p < 0.05). "
10/01/2011 - "The results of the present study are as follows; 1. After the 12-week experiment training, the findings indicated that the mean scores on bone resorption (beta-Crosslaps) of the experimental group and the control group were significantly different at 0.05 level. "
01/01/2017 - "There was no significant correlation between bone resorption marker β-crosslaps (β-CTX) and sFRP5. "
09/01/2015 - "After the 12-week training, the biochemical bone markers of both mini-trampoline and hard wooden surface aerobic dance training subjects decreased in bone resorption (β-CrossLaps) but increased in boneformation (P1NP). "
09/01/2015 - "In addition, there were no significant changes of bone resorption (β-CrossLaps) and bone formation (P1NP) between these two groups. "

12/01/2022 - "The ß-CrossLaps assay was effective for evaluating the efficacy of phytate on hypercalciuria during follow-up."
12/01/2022 - "All included patients were male or female, 18-65 years old, had hypercalciuria (> 250 mg/24 h), had a ß-Crosslaps level greater than 0.4 ng/mL, and had bone densitometry results indicative of osteopenia or osteoporosis in the femur and/or spine. "
03/01/2015 - "Patients in Group 2 presented greater loss of bone mineral density and more elevated alkaline phosphatase, iPTH, phosphorous and β-crosslaps levels, as compared to patients in Group 1. However, Group 1 presented greater urine calcium, oxalate and uric acid and a higher proportion of hypocitraturia, hypercalciuria and hyperoxaluria, as compared to Group 2. Multivariate analysis revealed that advanced age and β-crosslaps levels are risk factors for bone mineral density loss, while low urinary calcium excretion was protective against bone demineralization. "

09/01/1997 - "The rates of excretion of Crosslaps were significantly greater in patients with than in those without bone metastases. "
09/01/1997 - "Crosslaps had a higher specificity and positive predictive value than had PSA level in patients with bone metastases, and a higher sensitivity than bone ALP. "
03/01/2000 - "The new biochemical bone resorption markers especially Ntx i Crosslaps seems to be the most efficient for evaluation metastases response."
11/01/1999 - "The mean values of ICTP, CrossLaps, PINP and PICP were significantly higher in patients with bone metastases than in those without metastases or with only soft tissue metastases. "
01/01/2010 - "Results were compared with imaging techniques for the presence of metastases; bone ALP isoenzyme (B-ALP) results were compared with C-Terminal degradation products of type I collagen (S-CTX) (CrossLaps, IDS Nordic). "

06/01/2017 - "In group 2, higher levels of osteocalcin, β-crosslaps, urinary calcium, fasting urine calcium/creatinine, 24 h urine calcium/creatinine and 24 h oxaluria were observed compared to group 1. In the multivariate analysis, only the β-crosslaps and urinary calcium were independently associated with osteoporosis. "
03/01/2015 - "Patients in Group 2 presented greater loss of bone mineral density and more elevated alkaline phosphatase, iPTH, phosphorous and β-crosslaps levels, as compared to patients in Group 1. However, Group 1 presented greater urine calcium, oxalate and uric acid and a higher proportion of hypocitraturia, hypercalciuria and hyperoxaluria, as compared to Group 2. Multivariate analysis revealed that advanced age and β-crosslaps levels are risk factors for bone mineral density loss, while low urinary calcium excretion was protective against bone demineralization. "

01/01/2003 - "Among biochemical tests, bone resorption markers (Pyr, Dpyr, CrossLaps) appeared to be the most useful; treatment of bone fractures should be evaluated by X-ray examinations."